Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases

2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases

US Patent 6458822 · Granted Oct 1, 2002

Estimated economic value: $404,760,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HER2 mutation inhibitors2025
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhi2025
Compounds for the treatment of BRAF-associated diseases and disorders2025
Chemical compounds2024
Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors2023
Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases2023
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhi2023
Chemical compounds2023
Compounds for the treatment of BRAF-associated diseases and disorders2023
Compounds for the treatment of BRAF-associated diseases and disorders2022
Bicyclic fused pyridine compounds as inhibitors of TAM kinases2022
Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases2021